205 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry

6879

TCI GENE
NT$78.000%-35.5%NT$2.1bn/aPE176.8xn/a2.6%Healthcare

6527

Crystalvue Medical
NT$80.602.9%4.0%NT$2.0bNT$92.00PE19.7xn/a2.6%Healthcare

3164

GenMont Biotech Incorporation
NT$23.15-0.2%-4.7%NT$2.0bn/aPE60.7xn/a3.0%Pharmaceuticals & Biotech

6645

Kim Forest Enterprise
NT$38.80-1.4%29.9%NT$1.9bn/aPS4.7xn/a0.2%Pharmaceuticals & Biotech

4133

Abnova (Taiwan)
NT$32.001.3%-7.8%NT$1.9bn/aPE44.4xn/a2.3%Pharmaceuticals & Biotech

4121

Rossmax International
NT$22.75-0.9%-23.9%NT$1.9bn/aPB1.3xn/a0%Healthcare

6892

Taiwan Bio Therapeutics
NT$36.95-1.3%-5.1%NT$1.9bn/an/an/an/aPharmaceuticals & Biotech

4171

GeneReach Biotechnology
NT$32.350.6%-23.4%NT$1.9bn/aPS8.2xn/a0%Healthcare

6748

ACRO Biomedical
NT$30.003.6%14.5%NT$1.8bn/an/an/an/aPharmaceuticals & Biotech

4745

Cowealth Medical Holding
NT$23.700.9%-14.7%NT$1.8bn/aPE32.9xn/a1.7%Healthcare

4161

Bioptik Technology Incorporation
NT$33.90-4.9%5.0%NT$1.8bn/aPE21xn/a0%Healthcare

4127

Tien Liang BioTech
NT$39.20-0.1%163.1%NT$1.8bn/aPE101.2xn/a0%Pharmaceuticals & Biotech

7729

Steminent Biotherapeutics
NT$31.45-5.0%n/aNT$1.8bn/an/an/an/aPharmaceuticals & Biotech

1780

Allied Biotech
NT$17.901.7%-4.0%NT$1.7bn/aPE17.6xn/a4.7%Pharmaceuticals & Biotech

6872

NaviFUS
NT$30.400.2%8.2%NT$1.7bn/an/an/an/aHealthcare

6562

UBI Pharma
NT$14.252.2%-62.3%NT$1.7bn/aPE2097.4xn/a0%Pharmaceuticals & Biotech

4192

SynCore BiotechnologyLtd
NT$46.85-1.3%-32.3%NT$1.6bn/aPS81.6xn/an/aPharmaceuticals & Biotech

6598

Applied BioCode
NT$20.001.3%-26.5%NT$1.6bNT$22.00PS4.1xn/an/aHealthcare

4173

Arich Enterprise
NT$21.80-0.5%1.4%NT$1.6bn/aPE21.2xn/a4.2%Healthcare

7575

Amed
NT$54.00-3.6%-11.2%NT$1.6bn/an/an/an/aHealthcare

6847

Puriblood Medical
NT$113.500%-11.7%NT$1.6bn/aPS12.9xn/an/aHealthcare

6827

MegaPro Biomedical
NT$24.201.5%-11.0%NT$1.6bn/an/an/an/aPharmaceuticals & Biotech

6973

U-Neuron Biomedical
NT$53.001.3%n/aNT$1.6bn/an/an/an/aPharmaceuticals & Biotech

6939

TFBS Bioscience
NT$43.301.4%n/aNT$1.5bn/an/an/an/aPharmaceuticals & Biotech
Page 6 of 9
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.